Regulatory Insights

  1. FDA Approvals Of Two Novel Agents For The Acute Treatment Of Migraine 7/31/2026

    Parallel trials, compressed timelines, thousands of patients. Discover the data oversight strategies that kept two programs on track to approval

  2. The FDA Just Rewrote The Rules For Clinical Trials. Here's What It Means For RTSM. 7/30/2026

    Learn how evolving trial designs are changing RTSM requirements and driving demand for greater flexibility, traceability, and execution quality.

  3. Real-Time Trials Need Real-Time Data You Can Trust 7/30/2026

    The FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.

  4. The Renaissance Of Psychedelic Research: History, Protocols, And Forward Trajectories 7/30/2026

    Discover how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research.

  5. Making Early Decisions In Psychiatric Drug Development 7/30/2026

    Quantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric

  6. EU Clinical Trial Regulation Timelines: Shorter Than Many Expect 7/30/2026

    The EU CTR rewards early planning. Strong documentation, regulatory readiness, and aligned partners can help accelerate approvals and reduce delays.

  7. Why Driving Impairment Evaluation Is Becoming More Important In CNS Drug Development 7/30/2026

    Vague warning labels leave patients and prescribers guessing about driving safety. Discover recent compliance data and learn how simulation studies clarify real-world functional risk.

  8. Building the Blueprint: What Psychedelic Trials Need Now 7/29/2026

    Discover how leading experts are addressing recent regulatory reviews to shape the next phase of psychedelic clinical research.

  9. What 9 Years Of MDR Experience Is Changing About PMCF Planning 7/28/2026

    Re-evaluate your compliance roadmap by exploring expert perspectives on navigating regulatory shifts, distinguishing core surveillance obligations, and building a defensible, value-driven clinical data strategy.

  10. UK Clinical Trial Regulations Reform 7/24/2026

    UK trial regulations have been overhauled. Learn what faster approval pathways, stricter publication rules, and longer retention requirements mean for your operations.